HIV-1 subtypes and circulating recombinant forms (CRFs) from HIV-infected patients residing in two regions of central and southern Italy

Journal of Medical Virology

Volumn 75, Issue 4, 2005, Pages 483-490

  Monno, Laura ^a   Brindicci, Gaetano ^a   Lo Caputo, Sergio ^b   Punzi, Grazia ^a   Scarabaggio, Teresa ^a   Riva, Chiara ^c   Di Bari, Cesare ^d   Pierotti, Piera ^b   Saracino, Annalisa ^e   Lagioia, Antonella ^a   Mazzotta, Francesco ^b   Balotta, Claudia ^c   Angarano, Gioacchino ^e  

^a UNIVERSITY OF BARI   (Italy)

^b SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Ospedale Pediatrico Giovanni XXIII   (Italy)

^e UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Circulating recombinant forms; HIV 1; Italy; Subtypes

Indexed keywords

ADULT; ARTICLE; CHILD; ENDEMIC DISEASE; FEMALE; GENE SEQUENCE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRANT; ITALY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREVALENCE; SEXUAL BEHAVIOR; SOCIAL ASPECT; STRUCTURAL GENE; UNINDEXED SEQUENCE; VIRUS RECOMBINANT; VIRUS TYPING;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; EMIGRATION AND IMMIGRATION; FEMALE; GENE PRODUCTS, POL; HIV INFECTIONS; HIV-1; HUMANS; ITALY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 20044395615     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20300     Document Type: Article

References (32)

1. Andersson S, Norrgren H, Dias F, Biberfeld G, Albert J. 1999. Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from Guinea-Bissau with single or dual infections: Predominance of a distinct HIV-1 subtype A/G recombinant in West Africa. Virology 262:312-320.
2. Angarano G, Pastore G, Monno L, Santantonio T, Luchena N, Schiraldi O. 1985. Rapid spread of HTLV-III infection among drug addicts in Italy. Lancet 2:1302.
3. Apetrei C, Loussert-Ajaka I, Collin G, Letoumeur F, Duca M, Saragosti S, Simon F, Brun-Vezinet F. 1997. HIV type 1 subtype F sequences in Romanian children and adults. AIDS Res Hum Retroviruses 13:363-365.
4. Balotta C, Facchi G, Violin M, Van Dooren S, Cozzi-Lepri A, Forbici F, Bertoli A, Riva C, Senese D, Caramello P, Camevale G, Rizzardini G, Cremonini L, Monno L, Rezza G, Pemo CF, Ippolito G, d'Arminio-Monforte A, Vandamme AM, Moroni M; ICONA Study Group. 2001. Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences. J Acquir Immune Def Syndr 27:499-505.
5. Boni J, Pyra H, Gebhardt M, Perrin L, Burgisser P, Matter L, Fierz W, Erb P, Piffaretti JC, Minder E, Grob P, Burckhardt JJ, Zwahlen M, Schupbach J. 1999. High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. J Acquir Immune Def Syndr 22:174-179.
6. Caride E, Hertogs K, Larder B, Dehertogh P, Brindeiro R, Machado E, de Sa CA, Eyer-Silva WA, Sion FS, Passioni LF, Menezes JA, Calazans AR, Tanuri A. 2001. Genotypic and phenotypic evidence of different drug-resistance mutation patterns between B and non-B subtype isolates of human immunodeficiency virus type 1 found in Brazilian patients failing HAART. Virus Genes 23:193-202.
7. Centers for Disease Control and Prevention. 1993. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 269:729-730.
8. Couturier E, Damond F, Roques P, Fleury H, Barin F, Brunet JB, Brun-Vezinet F, Simon F. 2000. HIV-1 diversity in France, 1996-1998. The AC11 laboratory network. AIDS 14:289-296.
9. d'Arminio Monforte A, Lepri AC, Rezza G, Pezzotti P, Antinori A, Phillips AN, Angarano G, Colangeli V, De Luca A, Ippolito G, Caggese L, Soscia F, Filice G, Gritti F, Narciso P, Tirelli U, Moroni M. 2000. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. I.CO.NA. Study Group. Italian Cohort of Antiretroviral-Naïve Patients. AIDS 14:499-507.
10. Deroo S, Robert I, Fontaine E, Lambert C, Plesseria JM, Arendt V, Staub T, Hemmer R, Schneider F, Schmit JC, Robert I, Fontaine E. 2002. HIV-1 subtypes in Luxembourg, 1983-2000. AIDS 16:2461-2467.
11. Descamps D, Apetrei C, Collin G, Damond F, Simon F, Brun-Vezinet F. 1998. Naturally occurring decreased susceptibility of HIV-1 sub-type G to protease inhibitors. AIDS 12:1109-1111.
12. Felsenstein J. 1996. PHYLIP: Phylogeny Inference Package, version 3.52. Seattle, WA: University of Washington.
13. Gonzales MJ, Machekano RN, Shafer RW. 2001. Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: Classification, amino acid mutation patterns, and prevalence in a Northern California clinic-based population. J Infect Dis 184:998-1006.
14. Hirsch MS, Conway B, D'Aquila RT, Johnson VA, Brun-Vezinet F, Clotet B, Demeter LM, Hammer SM, Jacobsen DM, Kuritzkes DR, Loveday C, Mellors JW, Vella S, Richman DD. 1998. Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management. International AIDS Society-USA Panel. JAMA 279:1984-1991.
15. Holguin A, Aracil B, Alvarez A, Barros C, Soriano V. 2001. Prevalence of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICORHIV-1 MONITOR version 1.0 and the new automated version 1.5. J Clin Microbiol 39:1850-1854.
16. Irwin KL, Pau CP, Lupo D, Pienazek D, Luo CC, Olivo N, Rayfield M, Hu DJ, Weber JT, Respess RA, Janssen R, Minor P, Ernst J. 1997. HIV genetic diversity in North America. Presence of human immunodeciency virus (HIV) type 1 subtype A infection in a New York community with high HIV prevalence: a sentinel site for monitoring Centers for Disease Control and Prevention-Bronx Lebanon HIV serosurvey team. J Infect Dis 176:1629-1633.
17. Kanki PJ, Hamel DJ, Sankale JL, Hsieh C, Thior I, Barin F, Woodcock SA, Gueye-Ndiaye A, Zhang E, Montano M, Siby T, Marlink R, NDoye I, Essex ME, MBoup S. 1999. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 179:68-73.
18. Loemba H, Brenner B, Pamiak MA, Ma'ayan S, Spira B, Moisi D, Oliveira M, Detorio M, Wainberg MA. 2002. Genetic divergence of human immunodeficiency virus type 1 (HIV-1) Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against non-nucleoside inhibitors of RT. Antimicrob Agents Chemother 46:2087-2094.
19. McCutchan FE, Salminen MO, Carr JK, Burke DS. 1996. HIV-1 genetic diversity. AIDS 10:S13-S20.
20. McCutchan FE, Carr JK, Bajani M, Sanders-Buell E, Harry TO, Stoeckli TC, Robbins KE, Gashau W, Nasidi A, Janssens W, Kalish ML. 1999. Subtype G and multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria. Virology 254:226-234.
21. Monno L, Punzi G, Scarabaggio T, Saracino A, Brindicci G, Fiore JR, Iambrenghi OC, Di Stefano M, Pastore G, Angarano G. 2003. Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART. J Med Virol 70:1-9.
22. Montavon C, Toure-Kane C, Nkengasong JN, Vergne L, Hertogs K, Mboup S, Delaporte E, Peeters M. 2002. CRF06-cpx: A new circulating recombinant form of HIV-1 in West Africa involving subtypes A, G, K, and J. J Acquir Immune Defic Syndr 29:522-530.
23. Muller-Trutwin MC, Chaix ML, Letoumeur F, Begaud E, Beaumont D, Deslandres A, You B, Morvan J, Mathiot C, Barre-Sinoussi F, Saragosti S. 1999. Increase of HIV-1 subtype A in Central African Republic. J Acquir Immune Defic Syndr 21:164-171.
24. Ou CY, Takebe Y, Weniger BG, Luo CC, Kalish ML, Auwanit W, Yamazaki S, Gayle HD, Young NL, Schochetman G. 1993. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet 341:1171-1174.
25. Papa A, Papadimitriou E, Papoutsi A, Kiosses V, Antoniadis A. 2002. HIV-1 subtypes and circulating recombinant forms (CRFs) in Northern Greece. Virus Res 85:85-93.
26. Paraskevis D, Magiorkinis E, Magiorkinis G, Anastassopoulou C, Lazanas M, Chrysos G, Vandamme AM, Hatzakis A. 2001. Molecular characterization of a complex, recombinant human immunodeficiency virus type 1 (HIV-1) isolate (A/G/J/K/?): Evidence to support the existence of a novel HIV-1 subtype. J Gen Virol 82:2509-2514.
27. Snoeck J, Van Dooren S, Van Laethem K, Derdelinckx I, Van Wijngaerden E, De Clercq E, Vandamme AM. 2002. Prevalence and origin of HIV-1 group M subtypes among patients attending a Belgian hospital in 1999. Virus Res 85:95-107.
28. Thomson MM, Villahermosa ML, Vazquez-de-Parga E, Cuevas MT, Delgado E, Manjon N, Medrano L, Perez-Alvarez L, Contreras G, Carrillo MG, Salomon H, Najera R. 2000. Widespread circulation of B/F intersubtype recombinant form among HIV-1 infected individuals in Buenos Aires, Argentina. AIDS 5:897-899.
29. Thomson MM, Pérez-Alvarez L, Nàjera R. 2002. Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2:461-471.
30. Tscheming C, Alaeus A, Fredriksson R, Bjomdal A, Deng H, Littman DR, Fenyo EM, Albert J. 1998. Differences chemokines coreceptor usage between genetic subtypes of HIV-1. Virology 241:181-188.
31. van Harmelen J, Wood R, Lambrick M, Rybicki EP, Williamson AL, Williamson C. 1997. An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa. AIDS 11:81-87.
32. Vergne L, Peeters M, Mpoudi-Ngole E, Bourgeois A, Liegeois F, Toure-Kane C, Mboup S, Mulanga-Kabeya C, Saman E, Jourdan J, Reynes J, Delaporte E. 2000. Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: Evidence of many minor drug resistance mutations in treatment-naive patients. J Clin Microbiol 38:3919-3925.